Next Article in Journal
Prognostic Utility of Neutrophil-to-Lymphocyte Ratio in Patients with Metastatic Colorectal Cancer Treated Using Different Modalities
Previous Article in Journal
Cancer and COVID-19: How Understanding Grief Helps the Pandemic Frontlines
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Letter

The Case for Breast-Conservation Treatment Rates to Be a Quality Metric

1
MammoCare, 38 Irrawaddy Road, 06-21, Singapore 329563, Singapore
2
Department of Surgery, 986345 University of Nebraska Medical Center, Omaha, NE 68198, USA
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2020, 27(4), 442-443; https://doi.org/10.3747/co.27.6539
Submission received: 5 May 2020 / Revised: 10 June 2020 / Accepted: 14 July 2020 / Published: 1 August 2020

Abstract

We read the article titled “Mastectomy versus breastconservation therapy: an examination of how individual, clinicopathologic, and physician factors influence decision-making” by Gu et al. […]

Share and Cite

MDPI and ACS Style

Tan, M.P.; Silva, E. The Case for Breast-Conservation Treatment Rates to Be a Quality Metric. Curr. Oncol. 2020, 27, 442-443. https://doi.org/10.3747/co.27.6539

AMA Style

Tan MP, Silva E. The Case for Breast-Conservation Treatment Rates to Be a Quality Metric. Current Oncology. 2020; 27(4):442-443. https://doi.org/10.3747/co.27.6539

Chicago/Turabian Style

Tan, M.P., and E. Silva. 2020. "The Case for Breast-Conservation Treatment Rates to Be a Quality Metric" Current Oncology 27, no. 4: 442-443. https://doi.org/10.3747/co.27.6539

Article Metrics

Back to TopTop